A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults

A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetic characteristic of CTO0101

Inclusion Criteria:

• Healthy male and female volunteers
• Written informed consent to participate in the trial

Exclusion Criteria:

• Those who have a history of ophthalmic diseases and surgery within 5 years
• Smokers with an average daily smoking amount exceeding 10 cigarettes